Exhaled nitric oxide and bronchial hyperresponsiveness in patients with cough variant asthma or new-onset classic mild asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Exhaled nitric oxide and bronchial hyperresponsiveness in patients with a) mild asthma and b) seasonal allergic rhinitis. Relationship to symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001
Atopy but no bronchial hyperresponsiveness (BHR) is related to level of exhaled nitric oxide (FeNO) in children with allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008
Bronchial hyperresponsiveness (BHR) in children with allergic rhinitis (AR) and its relationship to exhaled nitric oxide (FeNO) Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
The relationship between exhaled nitric oxide, bronchial hyperresponsiveness and exercise-induced bronchospasm in Japanese children with asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Exhaled nitric oxide (FENO) in patients with rhinitis and asthma-like symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Exhaled nitric oxide as predictor of bronchial hyperresponsiveness to methacholine in subjects with respiratory symptoms Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007
Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Increased exhaled nitric oxide (E-NO) in asthmatics with bronchial hyperreactivity to MCh and UNDW Source: Eur Respir J 2001; 18: Suppl. 33, 164s Year: 2001
Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels Source: International Congress 2017 – Monitoring asthma control Year: 2017
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002
Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO) Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004